National Institutes of Health (NIH)
See the following -
SMART On The Agenda At AMIA 2012
The AMIA 2012 Annual Symposium begins today in Chicago, where it is currently “Informatics Week” as declared by Mayor Rahm Emanuel. Read More »
- Login to post comments
SPARC 2014 Open Access Meeting Speakers Accounced
SPARC (the Scholarly Publishing and Academic Resources Coalition) is pleased to announce a strong slate of speakers for its upcoming Open Access Meeting, to be held March 3 and 4 in Kansas City, MO. Dr. Philip Bourne, the newly-appointed Associate Director for Data Science at the National Institutes of Health, will deliver the opening keynote address. Read More »
- Login to post comments
Stanford’s John Ioannidis On “Underperforming Big Ideas”
In a thought-provoking JAMA commentary out today, Stanford’s John Ioannidis, MD, DSc, and two colleagues call for biomedical researchers — and funding institutions — to “sunset underperforming initiatives.” Nothing controversial there, until you go on to read that some of those initiatives are in the popular fields of gene therapy, stem cell therapy or precision medicine. And, they write, perhaps some less-successful projects have been pursued simply because they fall within a top research field.
- Login to post comments
Steal This Research Paper! (You Already Paid for It.)
Before Aaron Swartz became the open-access movement's first martyr, Michael Eisen was blowing up the lucrative scientific publishing industry from within. Read More »
- Login to post comments
Strapped For Funding, Medical Researchers Pitch To The Crowd
In April, Dyer turned to Medstartr, one of several new crowd-funding websites tailored for scientific research and the healthcare sector. Medstartr, which debuted online in July, focuses on helping biomedical start-ups solicit small donations from everyday citizens. Meanwhile, Petridish, which came online 6 March, and iAMscientist, on 31 July, are helping scientists affiliated with academic or nonprofit institutions raise money for their research.
- Login to post comments
Study: Elite Scientists Can hold Back Science
Recently, researchers at the National Bureau of Economic Research (NBER) released a working paper — titled, "Does Science Advance One Funeral at a Time?" — that puts Planck's principle to the test. Sifting through citations in the PubMed database, they found evidence that when a prominent researcher suddenly dies in an academic subfield, a period of new ideas and innovation follow. The NBER team identified 12,935 "elite" scientists — based on the amount of funding they receive, how many times they've published, how many patents they invented, or whether they were members of the National Academies of Sciences or the Institute of Medicine...
- Login to post comments
Suber: Leader Of A Leaderless Revolution
What is remarkable about the open access (OA) movement is that despite having no formal structure, no official organization, and no appointed leader, it has (in the teeth of opposition from incumbent publishers) triggered a radical transformation in a publishing system that had changed little in 350 years... Read More »
- Login to post comments
Sunday Shutdown Reader: Harold Varmus On Self-Destruction In The Sciences
"Now that the shutdown is nearing the end of its second week, further consequences are coming into view ..." Read More »
- Login to post comments
Superbugs Spread Across U.S.
As Americans worry about Ebola, the swiftly spreading virus that has traveled from West Africa to Texas, a more silent killer poses a greater danger...Drug-resistant bacteria killed 23,000 people in America last year and caused 2 million illnesses...
- Login to post comments
Syapse Joins Free The Data! Initiative and Provides Software To Power Participant-centric Hereditary Gene Mutation Data
Syapse, the leader in software for bringing omics into routine medical use, announced that it has joined the Free the Data! initiative. [...] Read More »
- Login to post comments
Telemedicine in Clinical Trials Highlighted At Upcoming Conferences
...At the Mobile and Clinical Trials Conference on September 10 and the 4th annual Dpharm: Disruptive Innovations in Clinical Trials Conference September 11-12, panelists will describe how telemedicine technology from AMC Health, a pioneer in providing telemedicine solutions for clinical trials, is being used to overcome these limitations...
- Login to post comments
The $100,000-Per-Year Pill: How US Health Agencies Choose Pharma Over Patients
Don Reichmuth survived prostate cancer once before, back in 2007, so his physician was concerned when tests recently revealed the cancer had returned. Reichmuth's physician prescribed a drug called enzalutamide, marketed by the Japanese company Astellas Pharma, Inc. under the brand name Xtandi. But when the physician sent the prescription to the pharmacy, the managers of Reichmuth's insurance plan sent back an immediate refusal to approve it. Reichmuth, a retired teacher who lives in Washington State, was puzzled by the logic. Then he learned the price of the Xtandi prescription: over $9,700 each month...
- Login to post comments
The Administration's Cancer Moonshot Will Just Start Coming Together as They Leave Office, but Republicans Can Keep It Going.
When President John F. Kennedy made his moonshot speech in September 1962, he thought he had at least two years left in office—over six if he got reelected. Plus, his party controlled Congress, giving him even more power to reach that goal. President Obama announced his moonshot to cure cancer (to be headed by VP Joe Biden) in his final State of the Union address. This week the administration revealed in a memorandum that the program may not be fully fleshed out until the final weeks of Obama's second term—with Republicans likely still holding Congress and perhaps entering the White House...
- Login to post comments
The Biothreat Is Real — And We’re Not Ready, Report Says
It's a scary scenario: A genetically engineered Nipah virus is sprayed into the air during a July 4th celebration in Washington, D.C., and across the country, killing more than 6,000 people. A badly prepared United States does almost nothing at first, and people die as officials scramble to get a grip on what happened...
- Login to post comments
The Doctor Is In
I’m a little underslept today,” Dr. Francis Collins laughs, sitting in his office in the historic Building 1 of the National Institutes of Health’s sprawling campus in Bethesda, Md., where he presides as the dean of the nation’s health. [...] Read More »
- Login to post comments